Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

StemCellPinheadWeb

Regenerative medicine: small steps towards the great leap forward

August 16, 2010 Research and Development GSK, Pfizer, Stem cells, regenerative medicine

Susan Aldridge reports on what some of the leading pharma companies are doing in the regenerative medicine and stem cells …
Feature

Merck signs Alzheimer’s deal with Alectos

August 16, 2010 Research and Development, Sales and Marketing Alzheimer's, Alzheimers, Merck & Co

Merck has entered a $289 million agreement with Canadian company Alectos Therapeutics in a bid to find new Alzheimer’s drugs. …
News
Amgen

Amgen’s Vectibix fails late stage trial

August 12, 2010 Research and Development, Sales and Marketing Amgen, Vectibix, head and neck cancer

Amgen’s potential head and neck cancer treatment Vectibix has failed to meet its primary endpoint of improving overall survival in …
News

Pharminox promotes Dr Marc Hummersone

August 12, 2010 Research and Development Pharminox, appointment, research and development

Nottingham, UK-based cancer drug discovery and development company Pharminox has appointed Dr Marc Hummersone as research director. Marc first joined …
Appointment

US biotech investment doubles

August 11, 2010 Research and Development biotech, funding

Investment in the beleaguered US biotechnology sector shot up in the second quarter of this year, but analysts say it’s …
News

Quintiles relocates European headquarters

August 11, 2010 Research and Development, Sales and Marketing Quintiles

Contract research organisation and pharma services company Quintiles is moving its European headquarters to Reading in the UK. Previously based …
News

Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 1

August 11, 2010 Research and Development Kinapse, life sciences, pharma

Valuations are essential components of effective transactions in the life sciences industry
Feature
White paper

Sanofi signs personalised medicine alliance

August 11, 2010 Research and Development Sanofi-Aventis, Scripps Genomic Medicine, genomics

Sanofi-Aventis has signed a personalised medicine research alliance with US not-for-profit company Scripps Genomic Medicine. The company is part of …
News
Sir_John_Savill

Sir John Savill to head up MRC

August 11, 2010 Research and Development MRC, appointment, research and development

The Medical Research Council has appointed Sir John Savill as chief executive and deputy chair with effect from 1 October. …
Appointment

Medical Affairs at the centre of life sciences innovation

August 11, 2010 Research and Development Kinapse, Medical Affairs

In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …
Feature

Elan halts separation plans

August 10, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Elan

Irish drugmaker Elan has postponed plans to separate its business into two publicly-listed companies due to adverse market conditions. Elan …
News

ACM Global expands UK and US teams

August 10, 2010 Manufacturing and Production, Research and Development ACM Global, appointment, manufacturing and production, research and development

Clinical services company ACM Global has made several new appointments at its UK and US facilities. Its Global Central Laboratory …
Appointment

CMP Therapeutics appoints Dr Neill Moray Mackenzie

August 9, 2010 Research and Development CMP Therapeutics, appointment, research and development

Dr Neill Moray Mackenzie has joined Hertfordshire, UK-based biopharmaceutical company CMP Therapeutics as chief executive. He has a long record …
Appointment

Doctors reach online tipping point: is pharma ready to respond?

August 5, 2010 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMA, Doctors.net.uk, GMC, GPs, Lansley, doctors, medeconnect, professional network

 This article was originally published by PharmaPhorum in Spring 2010.  
Feature
Thought Leadership

Daiichi’s lung cancer drug progresses to phase III

August 5, 2010 Research and Development Daiichi, arq 197, arqule, lung cancer, phase III

Daiichi Sankyo and biotech firm Arqule are to move their lung cancer treatment ARQ 197 into phase III trials. The …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026